News Snapshot:
A popular Chinese medical news site has been censored by the government for “violating applicable legislation and regulations,” months after its complaint about a government-backed Covid-19 herbal remedy sent the shares of a pharmaceutical giant tumbling. DXY, which counts tech giant Tencent among its investors and manages a multitude of health-related services, questioned in the past the price of Lianhua Qingwen, an herb advertised for fever and sore throat, as a treatment for covid-19. China approved the concoction, which consists of ingredients such as honeysuckle and apricot seeds, as a remedy for covid-19 in 2020, and it was distributed to...